ENGN — enGene Therapeutics Share News
0.000.00%
Last trade - 00:00- $117.23m
- -$116.13m
enGene Holdings rises after H.C. Wainwright starts coverage with 'buy'
Brief: Engene Reports Full Year 2024 Financial Results And Provides A Business Update
Brief: Engene Holdings Inc Files For Mixed Shelf Offering Of Up To $300 Million- SEC Filing
Brief: Engene Announces $60 Mln Private Placement Financing
Brief: Detalimogene Demonstrates 71% Complete Response Rate At Any Time In Preliminary Analysis Of Legend Pivotal Cohort
Brief: Engene Reports Q2 2024 Financial Results
Brief: enGene Reports First Quarter 2024 Financial Results And Recent Corporate Progress
Brief: enGene Reports First Quarter 2024 Financial Results And Recent Corporate Progress
Brief: Engene Holdings - Closed A $200 Million Oversubscribed Private Financing, Expected To Extend Cash Runway Into 2027
Brief: enGene Announces Oversubscribed $200 Million Private Placement Financing
Brief: enGene Announces Leadership Succession Plan
Brief: Engene Holdings Announces Expanded $50 mln Debt Facility With Hercules Capital
Brief: enGene Holdings Board Size Increased To Five Members
U.S. STOCKS ON THE MOVE-O'Reilly Automotive, Mattel, Amazon
U.S. STOCKS ON THE MOVE-Meta, GE, Vicor
Brief: Forbion European Acquisition Says Further Extended Time Available To Consummate Its Business Combination From Sept 14 To Dec 14
Brief: Engene Inc And Forbion European Acquisition Corp Announce Agreement To Create Nasdaq-Listed Biotech Company
NASDAQ RESUMED AT 10:38 AM
NASDAQ RESUMED AT 10:14 AM